Mono/oligoclonal pattern of Kaposi Sarcoma‐associated herpesvirus (KSHV/HHV‐8) episomes in primary effusion lymphoma cells

Primary effusion lymphoma (PEL) is a rare lymphoma of B‐cell origin, developed in serous cavities. PEL tumor cells are latently infected with Kaposi sarcoma‐associated herpesvirus (KSHV) and in most cases co‐infected with Epstein‐Barr virus (EBV). In 15 primary PEL tumors including 10 EBV‐positive cases, we analyzed the fused terminal repeat (TR) regions of KSHV episomes using pulsed‐field gel electrophoresis and Southern blot. On the same genomic DNA samples, the cellular clonality was assessed by Southern blot and PCR detection of monoclonal immunoglobulin heavy chain (IGH) VDJ gene rearrangements, associated in the EBV‐infected cases, with Southern blot analysis of the fused termini of EBV episomes. Monoclonal IGH gene rearrangements were detected in 13 tumors using Southern blot, in 11 cases using PCR, and in all cases considering both methods. EBV infection was monoclonal in all EBV‐positive cases. However, only 5 PEL tumors were found to be monoclonally infected with KSHV. In the 10 other cases, we found a biclonal (2 bands; n = 4) or an oligoclonal pattern (3–6 bands; n = 6) of KSHV episomes. We hypothesized that the apparent discrepancy between viral and cellular clonalities in PEL might be due to several phenomena including complex mechanisms of genomic recircularization, insertion of duplicated sequences into the TR region and simultaneous infection of tumor cells with defective KSHV variants. KSHV infection of contaminating nontumoral cells, superinfection from lytically infected cells or viral integration events might also explain the oligoclonal pattern of KSHV infection. Several of these mechanisms, not mutually exclusive, might coexist in a single tumor. © 2005 Wiley‐Liss, Inc.

[1]  E. Cesarman,et al.  KSHV-Positive Solid Lymphomas Represent an Extra-Cavitary Variant of Primary Effusion Lymphoma , 2004, The American journal of surgical pathology.

[2]  Shou-Jiang Gao,et al.  Lytic Replication-Defective Kaposi's Sarcoma-Associated Herpesvirus: Potential Role in Infection and Malignant Transformation , 2004, Journal of Virology.

[3]  C. Boshoff,et al.  Distinct cellular origins of primary effusion lymphoma with and without EBV infection. , 2004, Leukemia research.

[4]  D. Ganem,et al.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. , 2004, The Journal of clinical investigation.

[5]  P. Moore,et al.  Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? , 2003, Annual review of microbiology.

[6]  L. Young,et al.  Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.

[7]  W. Wilson,et al.  Infection of Mesothelial Cells with Human Herpes Virus 8 in Human Immunodeficiency Virus–Infected Patients with Kaposi's Sarcoma, Castleman's Disease, and Recurrent Pleural Effusions , 2003, Modern Pathology.

[8]  D. Knowles.  Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. , 1996, Hematology/oncology clinics of North America.

[9]  N. Harris,et al.  KSHV- and EBV-associated germinotropic lymphoproliferative disorder. , 2002, Blood.

[10]  H Ye,et al.  Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. , 2001, Blood.

[11]  F. Sigaux,et al.  A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. , 2001, The hematology journal : the official journal of the European Haematology Association.

[12]  E. Macintyre,et al.  Rapid, multifluorescent TCRG Vγ and Jγ typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations , 2000, Leukemia.

[13]  C. Buchrieser,et al.  Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. , 2000, Journal of the National Cancer Institute.

[14]  E. Macintyre,et al.  Virological and Molecular Characterisation of a New B Lymphoid Cell Line, Established from an AIDS Patient with Primary Effusion Lymphoma, Harbouring Both KSHV/HHV8 and EBV Viruses , 2000, Leukemia & lymphoma.

[15]  B. Arnulf,et al.  Rapid, multifluorescent TCRG Vgamma and Jgamma typing: application to T cell acute lymphoblastic leukemia and to the detection of minor clonal populations. , 2000, Leukemia.

[16]  P. Narciso,et al.  Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease. , 1999, Annals of diagnostic pathology.

[17]  D. Burstein,et al.  Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. , 1999, The American journal of surgical pathology.

[18]  V. Maréchal,et al.  Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient. , 1999, Leukemia & lymphoma.

[19]  P. Monini,et al.  Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. , 1999, Blood.

[20]  R. Sun,et al.  Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease , 1999, Journal of Virology.

[21]  E. Cesarman,et al.  Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. , 1998, The American journal of pathology.

[22]  G. Gaidano,et al.  Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas) , 1998, Leukemia.

[23]  J. Haas,et al.  Persistent Infection of Epstein-Barr Virus-Positive B Lymphocytes by Human Herpesvirus 8 , 1998, Journal of Virology.

[24]  J. Aster,et al.  Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. , 1998, The New England journal of medicine.

[25]  É. Oksenhendler,et al.  Complete remission of a primary effusion lymphoma with antiretroviral therapy , 1998, American journal of hematology.

[26]  B. Haar,et al.  Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 , 1997, Journal of virology.

[27]  E. Cesarman,et al.  Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. , 1997, Blood.

[28]  J. Diebold,et al.  Human herpes virus 8 (Kaposi’s sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomas , 1997, Leukemia.

[29]  J. Russo,et al.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. Leverger,et al.  Simplified strategies for minimal residual disease detection in B‐cell precursor acute lymphoblastic leukaemia , 1996, British journal of haematology.

[31]  M. McGrath,et al.  The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[32]  E. Jaffe,et al.  Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. , 1996, Leukemia.

[33]  E. Cesarman,et al.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. , 1996, Blood.

[34]  M. McGrath,et al.  Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.

[35]  L. Picker,et al.  Primary body cavity-based AIDS-related lymphomas. , 1996, American journal of clinical pathology.

[36]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[37]  E. Cesarman,et al.  Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders , 1995 .

[38]  E. Cesarman,et al.  Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. , 1995, Blood.

[39]  J. V. van Dongen,et al.  Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results. , 1993, Leukemia.

[40]  W. Chan,et al.  Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease [published erratum appears in Blood 1993 Oct 1;82(7):2268] , 1993 .

[41]  S. C. Lin,et al.  Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. , 1993, Blood.

[42]  J. Lawrence,et al.  Sensitive, high-resolution chromatin and chromosome mapping in situ: Presence and orientation of two closely integrated copies of EBV in a lymphoma line , 1988, Cell.

[43]  N. Raab-Traub,et al.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.

[44]  Robert Walgate,et al.  Proliferation , 1985, Nature.

[45]  S. Soong,et al.  Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines. , 1982, Intervirology.

[46]  M. Nonoyama,et al.  Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells , 1976, Journal of virology.